ArticleFrontiers in cardiovascular medicine2025
Brugada syndrome diagnosed in a young woman occurring postpartum: case report and literature review.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brugada syndrome (BrS), a hereditary cardiac channelopathy linked to malignant arrhythmias and sudden cardiac death, exhibits significant gender disparity with higher prevalence in males. This case report details a rare occurrence of BrS in a 32-year-old primigravida who suffered an acute cardiopulmonary arrest 2 h postpartum. The patient, with no prior cardiac history or family history of sudden death, underwent an uncomplicated delivery but developed sudden pulselessness post-transfer to the ward. Immediate resuscitation and subsequent evaluations revealed a type I Brugada ECG pattern, while structural cardiac abnormalities, electrolyte imbalances, and other etiologies were excluded. Although genetic testing was negative for pathogenic variants, the clinical diagnosis of BrS was made. An implantable cardioverter-defibrillator (ICD) was implanted for secondary prevention. This case underscores the importance of recognizing BrS in atypical populations, advocating for heightened vigilance in postpartum women with unexplained cardiac events. Further research into female-specific risk factors and collaborative care frameworks is essential to optimize maternal and neonatal outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.